Artiva Biotherapeutics, Inc.
ARTV
$3.60
$0.020.42%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 0.00 | -- |
| SG&A Expenses | 5.26M | 4.95M | 5.12M | 4.95M | 4.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.90M | 22.81M | 22.17M | 18.27M | 18.34M |
| Operating Income | -22.90M | -22.81M | -22.17M | -18.27M | -18.34M |
| Income Before Tax | -21.53M | -21.25M | -20.31M | -16.10M | -17.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.53M | -21.25M | -20.31M | -16.10M | -17.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.53M | -21.25M | -20.31M | -16.10M | -17.47M |
| EBIT | -22.90M | -22.81M | -22.17M | -18.27M | -18.34M |
| EBITDA | -22.24M | -22.17M | -21.54M | -17.65M | -17.71M |
| EPS Basic | -0.88 | -0.87 | -0.83 | -0.66 | -0.92 |
| Normalized Basic EPS | -0.55 | -0.54 | -0.52 | -0.89 | -0.58 |
| EPS Diluted | -0.88 | -0.87 | -0.83 | -1.32 | -0.92 |
| Normalized Diluted EPS | -0.55 | -0.54 | -0.52 | -0.89 | -0.58 |
| Average Basic Shares Outstanding | 24.48M | 24.38M | 24.34M | 24.39M | 18.90M |
| Average Diluted Shares Outstanding | 24.48M | 24.38M | 24.34M | 24.39M | 18.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |